Go Back
AGENUS INC reports $70.9 million Q1 loss
By USInMinutes - May 09, 2023, 09:50 AM ET
Last Updated - Jul 18, 2023, 03:33 PM EDT
The company generated $22.90 million in quarterly revenue
AGENUS INC [AGEN] has reported fiscal Q1 loss of $70.90 million.
On a per-share basis, the DE based company said its diluted earnings are $0.22 .
The Biological Products, Except Diagnostic Substances firm posted revenue of $22.90 million in this period.
Also Read:
- Agenus to Provide Corporate Update and First Quarter 2023 Financial Report
- Agenus Announces Dividend of 5 Million Shares of MiNK Therapeutics
- Agenus’ Botensilimab in Combination with Balstilimab Shows 33% Durable Responses in Ovarian Cancer
- Agenus Reports Fourth Quarter and Full Year 2022 Financial Results and Outlines 2023 Objectives
- Agenus Reports Fourth Quarter and Full Year 2022 Financial Results and Outlines 2023 Objectives
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Sponsored
Sponsored
Read More from Investing
Popular News
Latest News